This nonrandomized clinical trial reports data from developing and validating a smartphone-based, media-facilitated artificial intelligence system for self-screening for ocular surface malignancies in the general population.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Mobile-Based Artificial Intelligence and Ocular Surface Malignancies | 0 | 15.2 | 01-07-2026 |
| 2 | AI-Based OCT for Diabetes Screening | 0 | 10.02 | 21-07-2026 |
| 3 | Machine Learning Models for Predicting Long-Term Visual Acuity in Highly Myopic Eyes | 0 | 9.79 | 01-12-2023 |
| 4 | Diverse Research Teams and Underrepresented Groups in Clinical Studies | 0 | 6.4 | 01-11-2023 |
| 5 | Свердловские дерматологи тестируют ИИ для диагностики рака кожи | 0 | 6.12 | 18-08-2026 |
| 6 | Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer | 0 | 10.24 | 01-07-2026 |
| 7 | Разработана цифровая система диагностики злокачественных изменений | 0 | 0 | 04-04-2025 |
| 8 | AI analyses of eye scans can detect diseases like diabetes, osteoporosis and thyroid disease in seconds | 7 | 9 | 29-06-2026 |
| 9 | AI-guided outreach increased cancer screenings and reduced mortality, new study finds | 5 | 8 | 07-07-2026 |